Fig. 20From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationThe PC group showed metastasis on the 8th day (B1) and 16th day (B2) in the prostate cancer group via COX-II immunohistochemistry. n = 10, mean + SD, p ≤ 0.05. Images were taken at 10× and 40×Back to article page